Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Open Prospective Comparative Non-interventional Study of Therapy for Threatened Miscarriage With Medicinal Products Utrogestan, 200 mg Capsules (Besins Healthcare SA, Belgium), and Duphaston, 10 mg Coated Tablets (Abbott Healthcare Products B.V., the Netherlands)

NCT03309735 is registered in ClinicalTrials.gov with Besins Healthcare as lead sponsor.

NCT NCT03309735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03309735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Open Prospective Comparative Non-interventional Study of Therapy for Threatened Miscarriage With Medicinal Products Utrogestan, 200 mg Capsules (Besins Healthcare SA, Belgium), and Duphaston, 10 mg Coated Tablets (Abbott Healthcare Products B.V., the Netherlands)
Lead sponsor
Besins Healthcare
Phase
Observational
Overall status
Completed
Start date
October 16, 2017
Completion date
December 22, 2017
Enrollment
1,241 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

threatened miscarriage